000 | 02002 a2200553 4500 | ||
---|---|---|---|
005 | 20250514025357.0 | ||
264 | 0 | _c20020409 | |
008 | 200204s 0 0 eng d | ||
022 | _a0950-9232 | ||
024 | 7 |
_a10.1038/sj.onc.1205265 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorrison, Bei H | |
245 | 0 | 0 |
_aInositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. _h[electronic resource] |
260 |
_bOncogene _cMar 2002 |
||
300 |
_a1882-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCaspase 8 |
650 | 0 | 4 | _aCaspase 9 |
650 | 0 | 4 |
_aCaspases _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGamma Rays |
650 | 0 | 4 | _aGene Expression Regulation, Enzymologic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-beta _xpharmacology |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPhosphotransferases (Phosphate Group Acceptor) _xphysiology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xphysiology |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRadiation-Sensitizing Agents |
650 | 0 | 4 | _aReceptors, TNF-Related Apoptosis-Inducing Ligand |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xgenetics |
650 | 0 | 4 |
_aRibonucleases _xgenetics |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
650 | 0 | 4 | _aTumor Stem Cell Assay |
700 | 1 | _aBauer, Joseph A | |
700 | 1 | _aHu, Jiadi | |
700 | 1 | _aGrane, Ronald W | |
700 | 1 | _aOzdemir, Aylin M | |
700 | 1 | _aChawla-Sarkar, Mamta | |
700 | 1 | _aGong, Bendi | |
700 | 1 | _aAlmasan, Alex | |
700 | 1 | _aKalvakolanu, Dhananjaya V | |
700 | 1 | _aLindner, Daniel J | |
773 | 0 |
_tOncogene _gvol. 21 _gno. 12 _gp. 1882-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.onc.1205265 _zAvailable from publisher's website |
999 |
_c11802767 _d11802767 |